Insider · CIK 0002092593

Daniel Mark James

Reports to the SEC for 1 company · SEATTLE, WA

Transactions

Companies

Filings

CIK

0002092593

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-26	ATOSATOSSA THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+63K sh	—	—	63,000
2025-10-14	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+578K sh	—	—	578,000

C/O ATOSSA THERAPEUTICS, INC. 1448 NW MARKET STREET, SUITE 500

SEATTLE, WA, 98107